JJP-1008

N/A

Report date: 2024/03/21 15:02:02

Base Information

Drug NameJJP-1008
Drug Alias NameJJP-1008
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 14 inhibitors
TargetsTumor necrosis factor receptor superfamily member 14
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJjp Biologics Sp. z o.o.
China Registration ClassN/A

Develop Information

Active CompaniesJjp Biologics Sp. z o.o.
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A